Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.
about
Population stratification of a common APOBEC gene deletion polymorphismTransfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study.MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospectsOccult hepatitis B virus infection among blood donors in ColombiaInvestigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region.T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc.Occult hepatitis B demonstrated by anti-HBc and HBV DNA in HIV-positive patientsOccult hepatitis B virus infection among Egyptian blood donors.Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.Molecular testing in the diagnosis and management of chronic hepatitis BHepatitis B virus infection and transfusion medicine: science and the occult.Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi ArabiaPrevalence of HBV DNA among 20 million seronegative blood donations in China from 2010 to 2015Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody.The role of anti-core antibody response in the detection of occult hepatitis B virus infection.Optimizing antiviral agents for hepatitis B management in malignant lymphomas.The underlying mechanisms for the 'anti-HBc alone' serological profile.Pathogenesis of occult chronic hepatitis B virus infectionHepatitis B serological changes following allogeneic bone marrow transplantation.Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis.Two cases of transfusion-transmitted hepatitis B virus (HBV) infection in a low-endemic country before implementation of HBV nucleic acid testing.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients.Improvements in hepatitis B virus screening before rituximab therapy: A community-based, safety-net hospital experience.Prevalence of occult hepatitis B infection in patients visiting tertiary care hospitalEvaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors.Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil.Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection.Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.Genotypic polymorphisms of hepatitis B virus provide useful information for estimating geographical origin or place of long-term residence of unidentified cadavers.Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.Occult hepatitis B infections among blood donors in Lao PDR.Detection and identification of occult HBV in blood donors in Taiwan using a commercial, multiplex, multi-dye nucleic acid amplification technology screening test.An overview of occult hepatitis B virus infection.A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.Occult hepatitis B: clinical viewpoint and management.Occult hepatitis B virus infection in Thai blood donors.Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-traMolecular Variants of Hepatitis B Surface Antigen (HBsAg)
P2860
Q21563457-3D44D3B9-7483-4999-9234-A1DF057D0E7DQ33459458-BC5FA689-EA5F-45E2-BAD6-021B51BB46F4Q33661037-52F23C2F-36B0-4663-BA28-F3108BD9BC9FQ34636134-EE3DC3A4-6145-4E1A-935F-086650834443Q35170895-10277E59-446A-46F5-A487-EC42C4C757BBQ35195474-A807391B-6B75-4C71-AC7C-050DBEBC8D58Q35623577-BEFB289D-5B5F-4A34-9CCF-3A8EC29235F7Q36589567-1FE2FA32-5E87-4D3C-800E-232ECB0D9B26Q36812851-7C576A1F-CFBF-454D-B892-7F52D851D8B4Q36876536-EBF6275F-316D-490D-AFB8-96FE277D2A2BQ36881140-22186B6D-C7D5-4984-9C39-C086182A7678Q37153782-04B5FA3D-9C17-4D22-8C47-CE5C9591ADC4Q37359249-3B82EF8B-709F-4F08-9ABD-800BE5187245Q37408535-6CAC8F18-FA55-4031-BF45-30451012838EQ37606206-05FEB1D8-55AF-4173-9AA9-5DAAD046827CQ37634106-87233E68-3437-43AD-BBC9-2B36879D1977Q37666948-B0E7B695-BDA7-4EB9-B0A2-DD5D9F3C6948Q37678975-4D0ABD3C-775E-4BAC-B002-8584E5FC3989Q37862591-8D61AB2C-01F7-41C1-BB65-EBFEEE977344Q38025445-95D788A1-C9E7-4AE6-922A-D42D5EC2D5AAQ38375943-1AB4D9EF-C4D2-4310-9FBD-22E5B283A8FBQ38403039-34F7E3B6-9553-412C-9F36-8C772A70211BQ38536404-819B25DC-E063-478B-A1A0-8C718357BA16Q39384102-91E5CB25-8ED6-4D4F-A435-A53F25685FFCQ40409921-1A24A8EB-F32A-4E1C-B6A2-0167FC334874Q40647527-3CF8A21C-FDB9-4403-81F4-3EA5FC4A29CBQ41107028-E8CEEA64-05EE-40A8-A726-AD67E7836AE9Q41900242-0526B946-AA7A-4C8D-A080-0A608038FA97Q42205189-40915E46-4D48-4EA2-83DD-A6328E8B2E88Q42258103-88661A97-EEEA-464B-8E1D-60A5DC77B482Q42270997-455CC806-21D9-4807-8255-F9317DD9186AQ42272307-61E1F1E8-FE28-49E4-87C1-AD2728361EDDQ42277833-46CA9EB2-9B99-41B6-8014-C69485E95AFEQ42279560-06ECA9BA-D476-4C97-B9B6-2F7F9A3320C2Q42722415-B632464F-F97B-4CAB-A7EC-80B79B6FFF83Q42977855-640C0132-3439-4E21-916F-B9C8756EC893Q43223881-642AC5C5-F3FB-4E85-918E-EC2AF2188A3AQ45369715-46D41C93-68D5-41C6-9F05-5CEE817CFA2FQ50522754-7F412DD9-E691-48A7-B313-F7C2472B2B41Q58808840-FB362310-77BA-4694-9265-AEA9A5F6E64E
P2860
Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Epidemiology of HBV infection ...... infection and the role of NAT.
@ast
Epidemiology of HBV infection ...... infection and the role of NAT.
@en
type
label
Epidemiology of HBV infection ...... infection and the role of NAT.
@ast
Epidemiology of HBV infection ...... infection and the role of NAT.
@en
prefLabel
Epidemiology of HBV infection ...... infection and the role of NAT.
@ast
Epidemiology of HBV infection ...... infection and the role of NAT.
@en
P50
P1476
Epidemiology of HBV infection ...... infection and the role of NAT.
@en
P304
P356
10.1016/S1386-6532(06)80007-7
P478
36 Suppl 1
P577
2006-05-01T00:00:00Z